These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 35227613)
21. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077 [TBL] [Abstract][Full Text] [Related]
22. Adrenocorticotropic Hormone-Secreting Neuroendocrine Tumor of the Rectum Demonstrated on 68Ga-DOTATATE and 18F-FDG PET Imaging. Szajer J; Yung G; Russo R; Mansberg R Clin Nucl Med; 2017 Oct; 42(10):773-775. PubMed ID: 28759524 [TBL] [Abstract][Full Text] [Related]
23. Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors. You H; Kandathil A; Beg M; De Blanche L; Kazmi S; Subramaniam RM Nucl Med Commun; 2020 Oct; 41(10):1060-1065. PubMed ID: 32732600 [TBL] [Abstract][Full Text] [Related]
24. Head-to-head comparison of Liu Q; Zang J; Yang Y; Ling Q; Wu H; Wang P; Lu L; Zhu Z Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4386-4395. PubMed ID: 34146130 [TBL] [Abstract][Full Text] [Related]
25. Cardiac hemangioma mimicking a neuroendocrine tumor on Shah A; Binkovitz L; Layman AJ; Bois MC; Nguyen B J Card Surg; 2022 Sep; 37(9):2849-2851. PubMed ID: 35502494 [TBL] [Abstract][Full Text] [Related]
26. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors]. Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914 [TBL] [Abstract][Full Text] [Related]
28. Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT. Isik EG; Kuyumcu S; Ozkan ZG; Has Simsek D; Sanli Y Clin Nucl Med; 2022 Jan; 47(1):e79-e80. PubMed ID: 34392280 [TBL] [Abstract][Full Text] [Related]
29. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors. Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577 [TBL] [Abstract][Full Text] [Related]
30. 68Ga-DOTATOC and 18F-FDG PET/CT for identifying the primary lesions of suspected and metastatic neuroendocrine tumors: A prospective study in Taiwan. Chen SH; Chang YC; Hwang TL; Chen JS; Chou WC; Hsieh CH; Yeh TS; Hsu JT; Yeh CN; Tseng JH; Chen TC; Yen TC J Formos Med Assoc; 2018 Jun; 117(6):480-487. PubMed ID: 28735662 [TBL] [Abstract][Full Text] [Related]
31. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary? Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539 [TBL] [Abstract][Full Text] [Related]
32. Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review. Evangelista L; Ravelli I; Bignotto A; Cecchin D; Zucchetta P Clin Imaging; 2020 Nov; 67():113-116. PubMed ID: 32559681 [TBL] [Abstract][Full Text] [Related]
33. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT. Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196 [TBL] [Abstract][Full Text] [Related]
34. Unusual Increased Blood Pool Activity on 68Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease. Sharma A; Navaz AJ; Pandey MK; Parent EE Clin Nucl Med; 2022 Feb; 47(2):137-139. PubMed ID: 34690295 [TBL] [Abstract][Full Text] [Related]
36. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report. Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606 [TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors. Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865 [TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation. von Falck C; Boerner AR; Galanski M; Knapp WH Eur J Nucl Med Mol Imaging; 2007 May; 34(5):812. PubMed ID: 17242919 [No Abstract] [Full Text] [Related]
39. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions. Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872 [TBL] [Abstract][Full Text] [Related]
40. Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung. Arslan E; Erol Ö; Beyhan E; Şahin R; Çermik TF Clin Nucl Med; 2021 Jun; 46(6):488-490. PubMed ID: 33661196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]